NM_181351.5:c.53-496G>A

Variant names:

• chr11-113201883-G-A
• rs965560
• NM_181351.5:c.53-496G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_181351.5(NCAM1):​c.53-496G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 152,082 control chromosomes in the GnomAD database, including 10,230 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.36 (10230 hom., cov: 32)
• Consequence: NCAM1 NM_181351.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.70
• Publications: 6 publications found

Genes affected

NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181351.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	NM_181351.5	MANE Select	c.53-496G>A		intron	N/A	NP_851996.2	P13591-2
	NCAM1	NM_001400624.1		c.53-496G>A		intron	N/A	NP_001387553.1
	NCAM1	NM_001400620.1		c.53-496G>A		intron	N/A	NP_001387549.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	ENST00000316851.12	TSL:5 MANE Select	c.53-496G>A		intron	N/A	ENSP00000318472.8	P13591-2
	NCAM1	ENST00000529356.5	TSL:1	c.53-496G>A		intron	N/A	ENSP00000482205.1	P13591-6
	NCAM1	ENST00000619839.4	TSL:5	c.53-496G>A		intron	N/A	ENSP00000480132.1	A0A087WWD4

Frequencies

GnomAD3 genomes AF: 0.356 AC: 54119 AN: 151964 Hom.: 10218 Cov.: 32

Gnomad AFR AF: 0.473

Gnomad AMI AF: 0.240

Gnomad AMR AF: 0.313

Gnomad ASJ AF: 0.314

Gnomad EAS AF: 0.406

Gnomad SAS AF: 0.363

Gnomad FIN AF: 0.212

Gnomad MID AF: 0.344

Gnomad NFE AF: 0.317

Gnomad OTH AF: 0.341

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.356 AC: 54160 AN: 152082 Hom.: 10230 Cov.: 32 AF XY: 0.350 AC XY: 26010 AN XY: 74350

African (AFR) AF: 0.472 AC: 19591 AN: 41464

American (AMR) AF: 0.312 AC: 4770 AN: 15286

Ashkenazi Jewish (ASJ) AF: 0.314 AC: 1088 AN: 3470

East Asian (EAS) AF: 0.406 AC: 2099 AN: 5172

South Asian (SAS) AF: 0.362 AC: 1742 AN: 4818

European-Finnish (FIN) AF: 0.212 AC: 2245 AN: 10590

Middle Eastern (MID) AF: 0.349 AC: 102 AN: 292

European-Non Finnish (NFE) AF: 0.317 AC: 21578 AN: 67968

Other (OTH) AF: 0.344 AC: 726 AN: 2110

Alfa AF: 0.327 Hom.: 4961

Bravo AF: 0.367

Asia WGS AF: 0.424 AC: 1473 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
CADD	Benign	0.88
DANN	Benign	0.43
PhyloP100		-1.7
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs965560; hg19: chr11-113072605;